XML 21 R7.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE COMMON SHARES AND SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Common Stock
Convertible Common Shares
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Retained Earnings
Balance at Dec. 31, 2021 $ 2,562,444 $ 20,281   $ 1,811,545 $ (5,948) $ 736,566
Balance, Shares at Dec. 31, 2021   162,251 1,512      
Net issuance of common stock under stock-based plans (4,192) $ 95   (4,287)    
Net issuance of common stock under stock-based plans (in shares)   754        
Stock-based compensation expense 39,056     39,056    
Repurchase of common stock (750,000) $ (903)       (749,097)
Repurchase of common stock (in shares)   (7,223)        
Cash dividends (52,617)         (52,617)
Settlements of convertible notes (213) $ 151   (364)    
Settlements of convertible notes (in shares)   1,211        
Exercise of convertible notes hedge call options   $ (151)   151    
Exercise of convertible notes hedge call options (in shares)   (1,211)        
Convertible common shares 1,512     1,512    
Convertible common shares (in shares)     (1,512)      
Cumulative-effect of change in accounting principle related to convertible debt (6,234)     (100,834)   94,600
Net income 543,200         543,200
Other comprehensive income/loss (78,831)       (78,831)  
Balance at Oct. 02, 2022 2,254,125 $ 19,473   1,746,779 (84,779) 572,652
Balance, Shares at Oct. 02, 2022   155,782 0      
Balance at Jul. 03, 2022 2,298,596 $ 19,735   1,721,586 (52,959) 610,234
Balance, Shares at Jul. 03, 2022   157,880 0      
Net issuance of common stock under stock-based plans 12,052 $ 21   12,031    
Net issuance of common stock under stock-based plans (in shares)   169        
Stock-based compensation expense 13,194     13,194    
Repurchase of common stock (204,201) $ (283)       (203,918)
Repurchase of common stock (in shares)   (2,267)        
Cash dividends (17,149)         (17,149)
Settlements of convertible notes (32) $ 26   (58)    
Settlements of convertible notes (in shares)   207        
Exercise of convertible notes hedge call options 0 $ (26)   26    
Exercise of convertible notes hedge call options (in shares)   (207)        
Net income 183,485         183,485
Other comprehensive income/loss (31,820)       (31,820)  
Balance at Oct. 02, 2022 2,254,125 $ 19,473   1,746,779 (84,779) 572,652
Balance, Shares at Oct. 02, 2022   155,782 0      
Balance at Dec. 31, 2022 2,451,294 $ 19,470   1,755,963 (49,868) 725,729
Balance, Shares at Dec. 31, 2022   155,759 0      
Net issuance of common stock under stock-based plans 13,503 $ 104   (13,399)    
Net issuance of common stock under stock-based plans (in shares)   838        
Stock-based compensation expense 46,775     46,775    
Repurchase of common stock (352,791) $ (420)       (352,371)
Repurchase of common stock (in shares)   (3,362)        
Cash dividends (51,119)         (51,119)
Settlements of convertible notes   $ 72   (72)    
Settlements of convertible notes (in shares)   585        
Exercise of convertible notes hedge call options   $ (72)   72    
Exercise of convertible notes hedge call options (in shares)   (585)        
Net income 331,698         331,698
Other comprehensive income/loss 1,940       1,940  
Balance at Oct. 01, 2023 2,441,300 $ 19,154   1,816,137 (47,928) 653,937
Balance, Shares at Oct. 01, 2023   153,235 0      
Balance at Jul. 02, 2023 2,434,883 $ 19,269   1,784,590 (30,472) 661,496
Balance, Shares at Jul. 02, 2023   154,148 0      
Net issuance of common stock under stock-based plans 17,206 $ 26   17,180    
Net issuance of common stock under stock-based plans (in shares)   207        
Stock-based compensation expense 14,367     14,367    
Repurchase of common stock (118,907) $ (141)       (118,766)
Repurchase of common stock (in shares)   (1,120)        
Cash dividends (16,909)         (16,909)
Settlements of convertible notes $ 25   (25)    
Settlements of convertible notes (in shares)   210        
Exercise of convertible notes hedge call options 0 $ (25)   25    
Exercise of convertible notes hedge call options (in shares)   (210)        
Net income 128,116         128,116
Other comprehensive income/loss (17,456)       (17,456)  
Balance at Oct. 01, 2023 $ 2,441,300 $ 19,154   $ 1,816,137 $ (47,928) $ 653,937
Balance, Shares at Oct. 01, 2023   153,235 0